Fortress Biotech spinoff developing an IV formulation of the opioid tramadol.
Industry: Health Care
First Day Return: +37.5%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 04/28/2017 |
Offer Price | $6.00 |
Price Range $5.00 - $7.00 | |
Offer Shares (mm) | 5.5 |
Deal Size ($mm) | $33 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 06/26/2017 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $33 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | New York, NY, United States |
Founded | 2015 |
Employees at IPO | 3 |
Website www.avenuetx.com |